Back to search
Buruli Ulcer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Buruli Ulcer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Buruli Ulcer trials you may qualify forThe goal of this interventional clinical trial is to determine if treatment with 2-4 weeks of telacebac (T) will completely heal lesions in participants with Bu…
Buruli ulcer (BU) is a skin Neglected Tropical Disease (NTD) that is caused by Mycobacterium ulcerans. It affects skin, soft tissues and bones causing long-term…
Skin-related Neglected Tropical Diseases (Skin NTDs) affect about 1.8 billion people worldwide, particularly in poor and rural communities where healthcare acce…
Background Neglected Tropical Diseases (NTDs) are a group of diseases that are more common among the poorest people in the poorest countries. People affected by…